December 2019 – content
Life Sciences
Abcam to buy protein-conjugation technology assets
New England Biolabs opens Australian subsidiary
IVD and synthetic biology focus of LGC’s fiscal 2019 purchases
Mesa Labs acquires immunoassay and peptide synthesis company
Danaher to sell assets to gain regulatory approval
Qiagen becomes acquisition target after pulling NGS systems R&D
Bruker pushes magnet strength beyond 1 GHz threshold
ProBioGen in licensing agreement with Bayer
Fluidigm launches new CyTOF labelling kit
General Laboratory
Bruker purchases micro-EPR specialist
Peak Scientific staff numbers reaches 500 mark
Lab Innovations increases attendance
Hamamatsu US turns 50
Thorlabs adds two more companies to acquisition tally
MEMS foundry joins Teledyne
Watson-Marlow headquartered in Falmouth for 50 years
KnowItAll attracts partners
SP Industries expands with sterile filling technology
Agilent opens UK spectroscopy R&D facility
Merck and Rigaku in R&D agreement
Process & hand-held instrumentation
Vision Engineering announces sales milestone
Sale of loss-making business to improve AHL’s liquidity
Financials
Qiagen down on restructuring charges
Losses deepen as Expedeon considers major asset divestiture
Third quarter results disappoint at Fluidigm
LGC revenues dominated by life science reference products
Mesa Labs terminates segment to start another
GEH Life Sciences sees double-digit organic growth
BD Biosciences sees US growth
HHT’s analytical instruments recover from grim 2018
Tosoh exports suffer with Specialty not exempted
Genevac weakens slightly after record fiscal 2017
Leybold below target despite positive economic climate
Triple whammy mires record quarter at Grace
Dynasil turns a loss without tax benefit
Demand in luggage CT drives Detection Technology
AHL turns back into profit in third quarter
Deferred project revenues buoy Diploma’s ENV business
Appointments